Clinical AI, drug discovery, devices, and regulatory approvals.
A 10-year follow-up of a small trial found that more than a third of patients with newly diagnosed peripheral spondyloarthritis achieved sustained drug-free remission after early golimumab treatment.
A sponsored analysis argues that experienced manufacturing and regulatory staff, not just lab science, determine whether therapies reach patients.
Higher-acuity ambulatory care is forcing health systems to plan outpatient buildings with hospital-level infrastructure and built-in flexibility for future clinical models.
A pharmaceutical CEO argues that reducing treatment burden through better formulations and dosing can matter as much as clinical efficacy for pediatric patients.
A University of Helsinki study using MEG identifies five different functional connectivity profiles in people with depression, suggesting the diagnosis covers multiple biological conditions.
A new review explains how diabetes disrupts immune cell transitions, keeping wounds inflamed and delaying repair.
A weekly medical podcast review finds no outcome difference between early septic shock approaches and links oral estrogen to higher thromboembolic risk.
A large observational study links loneliness and social isolation to fewer disease-free years, with the steepest losses in mental health for men.
A short course of pembrolizumab before surgery produced no recurrences after nearly three years in patients with a specific genetic form of bowel cancer.
A new Wellcome Global Monitor survey finds U.S. trust in science is above the world average, yet the country remains sharply split along religious, geographic, and educational lines.
A University College Cork study links both regular and decaf coffee to gut bacteria changes and lower stress, with decaf tied to memory and caffeine to attention.
A growing body of research shows that substance use disorder develops and responds to treatment differently in women, requiring gender-specific approaches rather than one-size-fits-all programs.
People with diabetes reported better next-day well-being after days with more glucose variability within safe range, suggesting overly strict control may be burdensome.
A new STAT investigation warns that employer-sponsored health insurance is deteriorating, with experts predicting 2027 will be even worse.
A new study of roughly 1,600 healthcare workers finds persistent long COVID symptoms in 11% six months after infection, with older, female, and chronically ill staff most affected.
Suspension of the de minimis exemption may delay or block prescription drugs mailed from Canada, affecting millions of Americans who rely on lower-cost imports.
A physician and AI researcher explains that reimbursement decisions hinge on evolving clinical evidence, payer-specific rules, and delayed feedback—not just language models.
An emergency physician's essay highlights how doctor age, shift timing, and decision fatigue can subtly influence care in the ED.